Ocular Drug Delivery Solutions

  1. Medical Device Risk Management 4/28/2022

    At Kymanox, we provide risk management solutions for medical device compliance with ISO 14971, Medical Device Directive (MDD) 93/42/EEC, and Medical Device Regulations (MDR). We partner with you and your team to develop strategic solutions to address the specific needs of your product. We provide support throughout the product development life cycle including development of a Risk Management File that incorporates risk analysis, hazard analysis, device monitoring, and more.

  2. Accelerate Development And Delivery Of Your Modern Medicines 4/28/2022

    We are your life science solutions partner who ensures you have the right end-to-end solutions to address challenges in early development, commercialization, and post-market for your combination products, biologics, pharmaceuticals, and medical devices.

  3. Glass Prefillable Syringe Solution Delivering Complex Biologics 5/9/2022

    BD Neopak™ XtraFlow™ Glass Prefillable Syringe solution leverages 8 mm needle length in combination with thin wall cannula to reduce pressure drop and enhance flow.

  4. A CDMO With Oral Solid Dose And Sterile Injectable Expertise 6/6/2022

    Societal specializes in modified-release formulations, including those for high potent and DEA controlled substances.

  5. Easy-To-Use 1 mL Disposable Autoinjector 6/8/2022

    BD Physioject™ 1 mL Disposable Autoinjector is an easy-to-use autoinjector designed to deliver fixed dose injections subcutaneously.

  6. Pharmaceutical Aseptic Filling Equipment 6/29/2022

    AST’s ASEPTiCell® and GENiSYS® systems combine industry-proven technologies such as robotics and isolator-barrier systems to provide flexible pharmaceutical aseptic filling and closing of ready-to-use vials, syringes, and cartridges with a single machine. These innovative platforms use a modular design approach to provide a truly adaptive system with the capabilities and features necessary for cGMP production of clinical and commercial sterile injectable products.

  7. Sterile Formulation Development 7/1/2022

    With over 20 years of experience, PCI’s strength lies in our ability to manage products with unique challenges ranging from small molecules presenting with solubility issues or a labile molecule that is only stable as a liquid presentation for a short time.

  8. Drug Product Services: Pre-Formulation To Commercial-Scale Production 8/17/2022

    Our experts support clients with pre-formulation, formulation, process and analytical development, as well as production and registration. We’ve worked on a range of both oral solid dosage and injectable projects for clients over the years.

  9. Biodegradable Polyester Amide Platform For Sustained Delivery Solutions 10/21/2022

    A robust synthetic polymer platform based on naturally occurring amino acids, TheraPEA was designed to address limitations associated with the use of traditional polymeric materials.

  10. Available Fill/Finish Capacity With Exceptional Manufacturing Flexibility 2/15/2023

    We can fill a wide range of container sizes and volumes in the clinical and commercial manufacturing of sterile injectables. Explore our capabilities in formulation and scale up, manufacturing, lyophilization, and extractables and leachables.